A generic blood pressure drug called prazosin, made by Teva Pharmaceuticals, is being recalled by the Food and Drug Administration because it contains elevated levels of cancer-causing chemicals called nitrosamines.
The recall, which Teva announced on Oct. 7, 2025, affects more than 580,000 prazosin capsules. Prazosin is prescribed to around 510,000 patients yearly and is used to treat post-traumatic stress disorder as well as high blood pressure.
